Last updated: Nov 20, 2026, 12:00 AM

Intellia Therapeutics Inc Exchange (NASDAQ, USD)

NTLA

9.86
+0.16 (+1.65%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
13.73%
3 year return (CAGR)
-26.63%
5 year return (CAGR)
-40.84%
10 year return (CAGR)
-3.40%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
1.38B
Price/Sales
23.22
Ent value
1.40B
Price/Book
1.90
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
9.70%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open9.98
Daily high10.46
Daily low9.70
Daily Volume6.59M
All-time high176.78
1y analyst estimate23.11
Beta1.82
EPS (TTM)-3.00
Dividend per share0.00
Ex-div date-
Next earnings date19 Feb 2026

Ready to capitalize on Intellia Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
NTLAS&P500
Current price drop from All-time high-94.42%-5.02%
Highest price drop-96.45%-56.47%
Date of highest drop8 Apr 20259 Mar 2009
Avg drop from high-58.57%-10.64%
Avg time to new high63 days12 days
Max time to new high1306 days1805 days